BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 22959217)

  • 1. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.
    Vellas B; Coley N; Ousset PJ; Berrut G; Dartigues JF; Dubois B; Grandjean H; Pasquier F; Piette F; Robert P; Touchon J; Garnier P; Mathiex-Fortunet H; Andrieu S;
    Lancet Neurol; 2012 Oct; 11(10):851-9. PubMed ID: 22959217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgo biloba for prevention of dementia: a randomized controlled trial.
    DeKosky ST; Williamson JD; Fitzpatrick AL; Kronmal RA; Ives DG; Saxton JA; Lopez OL; Burke G; Carlson MC; Fried LP; Kuller LH; Robbins JA; Tracy RP; Woolard NF; Dunn L; Snitz BE; Nahin RL; Furberg CD;
    JAMA; 2008 Nov; 300(19):2253-62. PubMed ID: 19017911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
    van Dongen MC; van Rossum E; Kessels AG; Sielhorst HJ; Knipschild PG
    J Am Geriatr Soc; 2000 Oct; 48(10):1183-94. PubMed ID: 11037003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.
    DeKosky ST; Fitzpatrick A; Ives DG; Saxton J; Williamson J; Lopez OL; Burke G; Fried L; Kuller LH; Robbins J; Tracy R; Woolard N; Dunn L; Kronmal R; Nahin R; Furberg C;
    Contemp Clin Trials; 2006 Jun; 27(3):238-53. PubMed ID: 16627007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
    Burns DK; Alexander RC; Welsh-Bohmer KA; Culp M; Chiang C; O'Neil J; Evans RM; Harrigan P; Plassman BL; Burke JR; Wu J; Lutz MW; Haneline S; Schwarz AJ; Schneider LS; Yaffe K; Saunders AM; Ratti E;
    Lancet Neurol; 2021 Jul; 20(7):537-547. PubMed ID: 34146512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
    J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761.
    Scherrer B; Andrieu S; Ousset PJ; Berrut G; Dartigues JF; Dubois B; Pasquier F; Piette F; Robert P; Touchon J; Garnier P; Mathiex-Fortunet H; Vellas B
    J Nutr Health Aging; 2015 Dec; 19(10):1009-11. PubMed ID: 26624212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
    Schneider LS; DeKosky ST; Farlow MR; Tariot PN; Hoerr R; Kieser M
    Curr Alzheimer Res; 2005 Dec; 2(5):541-51. PubMed ID: 16375657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the design differences between the Ginkgo Evaluation of Memory study and the GuidAge study.
    Williamson JD; Vellas B; Furberg C; Nahin R; Dekosky ST
    J Nutr Health Aging; 2008 Jan; 12(1):73S-9S. PubMed ID: 18165850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.
    McCarney R; Fisher P; Iliffe S; van Haselen R; Griffin M; van der Meulen J; Warner J
    Int J Geriatr Psychiatry; 2008 Dec; 23(12):1222-30. PubMed ID: 18537221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study.
    Winblad B; Andreasen N; Minthon L; Floesser A; Imbert G; Dumortier T; Maguire RP; Blennow K; Lundmark J; Staufenbiel M; Orgogozo JM; Graf A
    Lancet Neurol; 2012 Jul; 11(7):597-604. PubMed ID: 22677258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment.
    Rai GS; Shovlin C; Wesnes KA
    Curr Med Res Opin; 1991; 12(6):350-5. PubMed ID: 2044394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
    Johnson SK; Diamond BJ; Rausch S; Kaufman M; Shiflett SC; Graves L
    Explore (NY); 2006 Jan; 2(1):19-24. PubMed ID: 16781604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.